Red/near infrared (NIR) persistent luminescent nanoparticles (PLNPs) hold great potential as a new generation of probes for the detection and imaging of biomolecules. Based upon the consideration that a single nanoprobe could serve multiple purposes, the development of a multimodal nanoprobe that combined the properties of rechargeable persistent emitting luminescence, magnetic resonance imaging (MRI) and drug delivery has attracted our attention as a promising prospect in the field of nanotechnology directed toward biomedical applications. Herein, Gd2O3@mSiO2/ZnGa2O4:Cr3+,Bi3+ (ZGOCB) mesoporous nanoparticles that exhibit enhancement of red (∼695 nm) persistent luminescence (∼18 d) properties were synthesized by using mesoporous silica nanospheres both as morphology-controlling templates and vessels. Being composed of hybrid shell/core architecture and through surface functionalization, Gd2O3@mSiO2/ZGOCB mesoporous nanoparticles possess the capacity for in vivo and in situ real-time monitoring, targeting tumors and drug delivery. Simultaneously, Gd2O3@mSiO2/ZGOCB exhibits a prominent longitudinal relaxivity, indicating that these nanoparticles could also be used as magnetic resonance imaging agents. We believe that this rechargeable red persistent luminescence and MRI-based core/shell structure of the multimodal nanoprobe offers a promising nano-platform for both diagnostics and therapeutics of reactive species in living cells or in vivo.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: